As investors pile into psychedelics, idealism gives way to pharma economicsAs investors pile into psychedelics, idealism gives way to pharma economics - The Associated Press

Dozens of psychedelic startup companies are racing to begin selling mind-expanding drugs for depression and other mental health conditions, riding a wave of promising research and media hype. The rush to market has sparked patent battles among companies tryin…